Rigel Pharmaceuticals Aktie
WKN: 766093 / ISIN: US7665596034
05.08.2025 22:29:08
|
Rigel Pharmaceuticals Inc. Q2 Earnings Summary
(RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):
Earnings: $59.61 million in Q2 vs. -$1.03 million in the same period last year. EPS: $3.28 in Q2 vs. -$0.06 in the same period last year. Revenue: $101.68 million in Q2 vs. $36.84 million in the same period last year.
-Guidance: Full year revenue guidance: $270- $280 Mln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Rigel Pharmaceuticals IncShsmehr Nachrichten
Keine Nachrichten verfügbar. |